As an alternative approach to analyzing the consequences of PTEN mutations in the CRC cohort, we leveraged two published datasets probing PTEN lipid phosphatase activity (LPA) and protein abundance, in an approach similar to ref. 52. This evidence concerns the gene PTEN and colorectal carcinoma.